在MarketScan索赔数据中识别住院患者的死亡率,使用机器学习
Fenglong Xie1,2, Timothy Beukelman2, Dongmei Sun1
1Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pharmacoepidemiology and drug safety
|June 22, 2023
概括
机器学习模型使用索赔数据准确地识别住院病人的死亡. 这种方法克服了大型医疗保健数据集中缺少的出院状态信息,改善了流行病学研究.
科学领域:
- 医疗信息学 医疗信息学
- 流行病学 流行病学
- 机器学习 机器学习
背景情况:
- 在使用医疗保健索赔数据的流行病学研究中,住院患者死亡率至关重要.
- 2016年,MarketScan数据开始掩盖出院状态,影响了患者死亡的识别.
研究的目的:
- 开发和验证用于准确识别住院患者死亡率的机器学习算法.
- 为应对索赔数据中缺少放电状态信息的挑战.
主要方法:
- 从2011年至2015年使用的住院住院情况,缺失或隐藏出院状态.
- 采用机器学习模型,包括随机森林,对年龄,性别和出院后的活动等变量进行训练.
- 使用灵敏度和正预测值 (PPV) 评估模型性能.
主要成果:
- 分析了超过 130 万例住院病例.
- 这四种机器学习方法都表现良好,随机森林实现了88%的PPV和93%的灵敏度.
- 关键预测因素包括缺乏退休后索赔和退出医疗保健计划.
结论:
- 机器学习算法可以可靠地识别住院患者的死亡率,即使缺失出院状态.
- 这种方法使得在隐藏的医疗保健索赔数据中准确分析住院病人的死亡情况.
相关概念视频
Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
Actuarial Approach
99
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
99
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Steps in Outbreak Investigation
155
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
155
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Introduction To Survival Analysis
293
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
293


